A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal ...
Hosted on MSN
A Lyme disease vaccine may be on the way
Pfizer’s shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company isn’t giving up. Pfizer has announced that its new Lyme disease vaccine ...
Pfizer and Valneva intend to proceed with regulatory submissions for the vaccine candidate based on these topline phase 3 clinical findings. Topline results were announced from a phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results